Alberto Conti
Doctoral scientist
Alberto graduated in 2020 from the University of York, completing an undergraduate degree in Biochemistry with a Year in Industry. As part of his degree, he worked at the Adaptive Immunity Research Unit within GSK, where he characterised a tolerogenic sub-population of dendritic cells.
After graduating, Alberto joined the Roychoudhuri team in the Department of Pathology as part of the MRes/PhD CRUK Cambridge Centre training programme. His research focuses on better understanding the interface between the immune system and tumours to improve the efficacy of immunotherapy.
